Pay in 4 interest-free payments of $29.75 Learn more
Ships within 48 hours · Estimated delivery Aug 2 - Aug 7
Both imatinib and crenolanib potently inhibit the kinase activity of the fusion oncogene with IC50 values of 1 and 21 nM
PubMed PMID: 22733805
5)1(6)7/h21-29
Smiles: OC(=O)CCOCCOCC#CC1=CC2=C(C=C1)C(=O)N(C1CCC(=O)NC1=O)C2=O
Nicotinamide riboside Size:Contact [email protected] for quotation Both imatinib and crenolanib potentlyNicotinamide riboside, an orally active NAD+ precursor, increases NAD+ levels and activates SIRT1 and SIRT3. Nicotinamide riboside is a source of vitamin B3 (niacin) and enhances oxidative metabolism, protection against high fat diet induced metabolic abnormalities. Nicotinamide riboside reduces cognitive deterioration in a transgenic mouse model of Alzheimers disease. Product information CAS Number: 1341 23 7 Molecular Weight: 255. 25 Formula:
US$ 68.00
US$ 68.00
US$ 240.00
US$ 190.00
US$ 75.00
US$ 125.00
US$ 65.00
US$ 140.00
US$ 85.00
US$ 243.00
US$ 112.00
US$ 220.00